Reviews
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
BOC Sciences
Talquetamab | BOC Sciences
Talquetamab is an investigational bispecific antibody being studied for the treatment of multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. Talquetamab is a bispecific antibody that targets both G protein-coupled receptor family C group 5 member D (GPRC5D) and CD3, a protein complex found on T cells. By binding to GPRC5D on multiple myeloma cells and CD3 on T cells, talquetamab redirects the T cells to attack and kill the cancerous plasma cells. Talquetamab is being investigated for the treatment of relapsed or refractory multiple myeloma, particularly in patients who have received multiple prior lines of therapy and have become resistant to existing treatments.
More Scientific Products from BOC Sciences
-
NOV 04, 2025The Simple Way to Protein Research -
NOV 05, 2025xMAP Connect 2025 Virtual Series
-
NOV 06, 2025Precision Oncology Showcase
- See More
Opens in a new window
Opens an external site
Opens an external site in a new window